• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Clin Case Rep . Giant cell myocarditis following COVID-19 successfully treated by immunosuppressive therapy

tetano

Editor, Senior Moderator
Clin Case Rep


. 2022 Aug 9;10(8):e6196.
doi: 10.1002/ccr3.6196. eCollection 2022 Aug.
Giant cell myocarditis following COVID-19 successfully treated by immunosuppressive therapy


Afsaneh Amiri[SUP] 1 [/SUP], Golnaz Houshmand[SUP] 1 [/SUP], Sepideh Taghavi[SUP] 1 [/SUP], Monireh Kamali[SUP] 1 [/SUP], Mona Faraji[SUP] 1 [/SUP], Nasim Naderi[SUP] 1 [/SUP]



Affiliations

Abstract

It has been shown that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), by coronavirus disease 2019 (COVID-19), can lead to multi-organ impairment including cardiac involvement and immunological problems. Acute myocarditis is one of serious and fatal complications of COVID-19. In this case report, we present a 46-year-old lady with a history of lichen planus dermatitis who has developed a rapidly progressive heart failure after an episode of COVID-19. The pathologic examination of her endomyocardial biopsy specimens was compatible with GCM, and she was successfully treated with a combined immunosuppressive therapy regimen.

Keywords: COVID‐19; Giant cell; myocarditis.
 
Back
Top Bottom